🔓
Sign in as a Member to unlock the full view of HR.6045. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$29.99/mo already a Member? Sign in →
HR.6045 · 118TH CONGRESS

Curbing Illicit Drug Threats Act

Status
Dead
Official Source
Investability
40/100
Stage
COMMITTEE
Related Bills
0
Full Text
2,303 chars
Alive
No

What This Bill Does · Plain English

Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.

Frequently Asked Questions

Did HR.6045 pass?
HR.6045 did not pass and is no longer active. Final stage: COMMITTEE.

Full Bill Text

118 HR 6045 IH: Curbing Illicit Drug Threats Act U.S. House of Representatives 2023-10-25 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 118th CONGRESS 1st Session H. R. 6045 IN THE HOUSE OF REPRESENTATIVES October 25, 2023 Ms. Caraveo (for herself and Mr. Kean of New Jersey ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To direct the Comptroller General of the United States to conduct a study and submit a report on the efficacy of Federal drug surveillance systems, and for other purposes. 1. Short title This Act may be cited as the Curbing Illicit Drug Threats Act . 2. GAO study and report on efficacy of Federal drug surveillance systems (a) Study The Comptroller General of the United States shall conduct a study on— (1) the efficacy of Federal drug surveillance systems in providing up-to-date information on illicit drug use in the United States, including any limitations affecting such efficacy; and (2) how such systems are used to address illicit drug use in the United States. (b) Report Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall complete the study under subsection (a) and submit to Congress a report containing— (1) the findings and conclusions of such study; and (2) any recommendations for legislative or administrative actions to improve the efficacy of the Federal drug surveillance systems examined in such study, including any recommendations pertaining to interagency communication or data collection procedures. (c) Federal drug surveillance systems defined In this section, the term Federal drug surveillance systems includes— (1) the Drug Overdose Surveillance and Epidemiology System of the Centers for Disease Control and Prevention (commonly known as DOSE ); (2) the State Unintentional Drug Overdose Reporting System of the Centers for Disease Control and Prevention (commonly known as SUDORS ); (3) the National Drug Early Warning System of the National Institute on Drug Abuse (commonly known as NDEWS ); and (4) the Drug Abuse Warning Network of the Substance Abuse and Mental Health Services Administration (commonly known as DAWN ).
🔒 GovGreed Pro · Trading Intelligence on HR.6045 Get Access — $29.99/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-11-17. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]